We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

125 hedge funds and large institutions have $210M invested in Arena Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

47% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $931K

26% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 35

5% more funds holding

Funds holding: 119 → 125 (+6)

3% more capital invested

Capital invested by funds: $203M → $210M (+$6.69M)

Holders
125
Holders Change
+6
Holders Change %
+5.04%
% of All Funds
3.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
44
Reduced
35
Closed
7
Calls
$1.37M
Puts
$931K
Net Calls
+$436K
Net Calls Change
-$161K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$2.21M
2
BFA
BlackRock Fund Advisors
California
+$766K
3
TC
TFS Capital
Pennsylvania
+$642K
4
Millennium Management
Millennium Management
New York
+$581K
5
State Street
State Street
Massachusetts
+$477K

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.92M
2
SAM
Senzar Asset Management
New York
-$389K
3
Deutsche Bank
Deutsche Bank
Germany
-$247K
4
VKH
Virtu KCG Holdings
New York
-$233K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$178K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFP
101
Ausdal Financial Partners
Iowa
$18K – – –
GA
102
Geneva Advisors
Illinois
$18K – – –
SBIA
103
Sheaff Brock Investment Advisors
Indiana
$18K +$16.6K +1,000 New
Citadel Advisors
104
Citadel Advisors
Florida
$18K +$16.6K +1,001 New
Zurich Cantonal Bank
105
Zurich Cantonal Bank
Switzerland
$15K – – –
NFG
106
Next Financial Group
Texas
$9K +$498 +30 +6%
RFA
107
Reilly Financial Advisors
California
$9K +$4.97K +300 +150%
MA
108
MUFG Americas
New York
$9K +$8.13K +490 New
LTFS
109
Ladenburg Thalmann Financial Services
Florida
$8K +$829 +50 +11%
Royal Bank of Canada
110
Royal Bank of Canada
Ontario, Canada
$7K +$1.74K +105 +37%
TRCT
111
Tower Research Capital (TRC)
New York
$6K -$11.4K -688 -68%
PNC Financial Services Group
112
PNC Financial Services Group
Pennsylvania
$4K -$2.16K -130 -39%
CHP
113
Cable Hill Partners
Oregon
$4K – – –
CTC
114
Central Trust Company
Missouri
$4K +$3.32K +200 New
TWA
115
TCI Wealth Advisors
Arizona
$3K -$829 -50 -23%
IA
116
IFP Advisors
Florida
$3K – – –
PMFA
117
Plante Moran Financial Advisors
Michigan
$3K – – –
AIM
118
Acrospire Investment Management
Illinois
$2K -$6.8K -410 -76%
TCIM
119
TIAA CREF Investment Management
New York
$1.34K -$30.6K -1,845 -2%
IWMPD
120
Integrated Wealth Management (Palm Desert)
California
$1K – – –
JWA
121
JFS Wealth Advisors
Pennsylvania
$1K – – –
SFG
122
SevenBridge Financial Group
Pennsylvania
$1K – – –
Fifth Third Bancorp
123
Fifth Third Bancorp
Ohio
$1K +$1.24K +75 New
VOYA Investment Management
124
VOYA Investment Management
Georgia
$197 – – –
VKH
125
Virtu KCG Holdings
New York
– -$233K -13,646 Closed
2 3 4
5
6

ARNA Hedge Fund Activity: Q3 2016 in Review

125 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2016, worth a combined $210M — up 3.3% from $203M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ARNA positions and 7 closed out — a net gain of 7 holders — while 44 added to existing stakes and 35 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $2.21M. The largest seller was Wellington Management Group, cutting an estimated $1.92M.

  • 125 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2016, up from 119 in Q2 2016.
  • Funds reported $210M of Arena Pharmaceuticals Inc stock for Q3 2016, up 3.3% quarter-over-quarter.
  • 14 funds opened new Arena Pharmaceuticals Inc positions in Q3 2016 and 7 closed out, a net change of +7 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2016 was Renaissance Technologies, an estimated $2.21M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2016 was Wellington Management Group, an estimated $1.92M sold.

Based on aggregated 13F filings for Q3 2016.